Sintx Technologies (SINT) Cash from Financing Activities (2013 - 2026)
Sintx Technologies (SINT) posted quarterly Cash from Financing Activities of $247000.0 for Q1 2026, down 94.21% year-over-year from $4.3 million in Q1 2025, and down 10.51% quarter-over-quarter from $276000.0 in Q4 2025.
Sintx Technologies (SINT) Cash from Financing Activities (2013 - 2026) Analysis & Trends
Sintx Technologies' Cash from Financing Activities history runs 14 years deep, the most recent figure standing at $247000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 94.21% year-over-year to $247000.0; the TTM figure through Mar 2026 stood at $4.2 million (down 47.95% YoY), while the FY2025 annual figure was $8.2 million, down 9.83% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $247000.0, down from $276000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $11.5 million in Q1 2023, with the low at -$123000.0 in Q2 2025.
- The 5-year median for Cash from Financing Activities is $1.0 million (2024), against an average of $2.5 million.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities jumped 96025.0% in 2022, then tumbled 132.8% in 2024.
- Sintx Technologies' Cash from Financing Activities stood at $3.8 million in 2022, then plunged by 91.91% to $311000.0 in 2023, then sank by 132.8% to -$102000.0 in 2024, then jumped by 370.59% to $276000.0 in 2025, then slipped by 10.51% to $247000.0 in 2026.
- Business Quant data shows SINT's Cash from Financing Activities at $247000.0 in Q1 2026, $276000.0 in Q4 2025, and $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Sintx Technologies | 7.23 Mn | 7.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 247,000.00 |
| Mar 31, 2026 | 247,000.00 |
| Dec 31, 2025 | 276,000.00 |
| Dec 31, 2025 | 276,000.00 |
| Sep 30, 2025 | 3.78 Mn |
| Sep 30, 2025 | 3.78 Mn |
| Jun 30, 2025 | -123,000.00 |
| Jun 30, 2025 | -123,000.00 |
| Mar 31, 2025 | 4.27 Mn |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | -102,000.00 |
| Dec 31, 2024 | -102,000.00 |
| Sep 30, 2024 | 2.86 Mn |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 311,000.00 |
| Dec 31, 2023 | 311,000.00 |